Mol. Hum. Reprod. Advance Access published online on September 23, 2007
Molecular Human Reproduction, doi:10.1093/molehr/gam071
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Growth inhibition and apoptosis induced in human leiomyoma cells by treatment with the PPAR gamma ligand ciglitizone

1Department of Obstetrics and Gynecology 2Department of Physiology 3Department of Pathology 4Department of Laboratory Medicine, School of Medicine, Keimyung University, Daegu, Korea 5Department of Oncology, Lombardi Cancer Center, Georgetown University, 3970 Reservoir Road, NW, Washington, DC 20007, USA
To whom correspondence should be addressed: Chi-heum Cho M.D. Department of Obstetrics and Gynecology, Keimyung University, School of Medicine, 194 Dongsan-Dong, Jung-Ku, Daegu, 700-712 Korea, Tel: 82-53-250-7518; Fax: 82-53-250-7599; E-mail: chcho{at}kmu.ac.kr
The nuclear receptors PPARs (peroxisome proliferator-activated receptors) are transcription factors that play important roles in multiple disease conditions. The activation of PPARs by specific ligands is associated with growth suppression of several different types of human cancer, but the molecular mechanism responsible for this growth suppressive effect remains elusive. The aim of this study was to determine the distribution of PPAR
protein/mRNA expression in uterine leiomyomas and to identify the PPAR
induced signalling pathways responsible for the growth inhibition induced by treatment with ciglitizone, a synthetic ligand of PPAR
, in view of identifying targets that could possibly affect the viability and proliferation of uterine leiomyoma cells. Dose-response studies on proliferation found that uterine leiomyoma was more sensitive to inhibition by ciglitizone treatments than normal myometrium. We also found that ciglitizone significantly stimulated gene expression driven by a PPAR-responsive element in cultured leiomyoma cells and reduced the survival of leiomyoma cells relative to the control cells. The reduced survival of ciglitizone treated leiomyoma cells resulted from a mechanism that involved the FAS receptor-mediated apoptosis signalling cascade. These results suggest that uterine leiomyomas growth and differentiation might be modulated through PPAR
receptors and that PPAR
ligands may be of potential use for uterine leiomyoma treatment.
Key Words:
Uterine leiomyoma/PPAR
/Ciglitizone/Apoptosis
* These two authors have made equal contributions to the manuscript
Submitted on August 17, 2007; resubmitted on September 7, 2007; accepted on September 20, 2007.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S.-H. Kwon, J.-C. Park, S. Ramachandran, S.-D. Cha, K.-Y. Kwon, J.-K. Park, J.-W. Park, I. Bae, and C.-H. Cho Loss of Cyclin G1 Expression in Human Uterine Leiomyoma Cells Induces Apoptosis Reproductive Sciences, April 1, 2008; 15(4): 400 - 410. [Abstract] [PDF] |
||||
